Dataset from A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/00006806
下载链接
链接失效反馈官方服务：
资源简介：
This study is being conducted to assess varenicline and bupropion as aids to smoking
cessation treatment in subjects with and without an established diagnosis of major
psychiatric disorder and to characterize the neuropsychiatric safety profile (pre-specified
adverse events (AEs) in both of these populations).
创建时间：
2025-02-22
